Cart
sales@molnova.com
Octahydroaminoacridine succinate
CAS No. 866245-79-6
Octahydroaminoacridine succinate( —— )
Catalog No. M27908 CAS No. 866245-79-6
Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 458 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOctahydroaminoacridine succinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionOctahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
-
DescriptionOctahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number866245-79-6
-
Formula Weight320.389
-
Molecular FormulaC17H24N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCC(O)=O.Nc1c2CCCCc2nc2CCCCc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhai H, et al. Reactions of non-immunologic contact urticaria on scalp, face, and back. Skin Res Technol. 2012 Nov;18(4):436-41.
molnova catalog
related products
-
H-Tyr-Ile-Gly-Ser-Ar...
H-Tyr-Ile-Gly-Ser-Arg-NH2 is a hexapeptide that is an essential fragment of laminin responsible for efficient cell adhesion and receptor binding. H-Tyr-Ile-Gly-Ser-Arg-NH2 promotes various epithelial cell adhesion activities.
-
Schizophrenia Relate...
Schizophrenia Related Peptide
-
BQ-3020 TFA (143113-...
BQ-3020 (TFA) is a selective ETB receptor agonist that inhibits [125I] et-1 binding to the ETB receptor in the cerebellum with a 0.2nm IC50, causing vasoconstriction.
